Sampled Announces Selection as a Contractor supporting the Genomic Characterization Center by the National Cancer Institute effective 01/13/2025. Piscataway, NJ – Sampled, an integrated analytical biorepository and multiomics company, is proud to announce its selection as a Genomic Characterization Center for the Genome Characterization program of the National Cancer Institute (NCI), part of the National […]
Press Releases
Sampled Named One of the First Olink® Certified Service Providers.
Piscataway, NJ, 5/3/2024 – Sampled1 today announced that it has been named one of the first Olink® Certified Service Providers Olink’s state-of-the-art proteomics technology enables understanding of complex biological pathways and disease markers. Proteomics technology is an important tool for studying diseases, providing crucial insights into their underlying molecular mechanisms. The consistent and highly accurate […]
Sampled Announces Leadership Transition
Industry Veteran John DelliSanti Appointed CEO Noel Figueroa Appointed Interim CFO Positioned to Accelerate Mission to Support Every Transformative Health Innovation Piscataway, NJ, 4/26/24 – Sampled, the next-generation laboratory that unlocks the valuable data in any biological sample, today announced the appointment of John DelliSanti as CEO, effective immediately. He succeeds Robin Grimwood, who will […]
Sampled Named a Certified Service Provider for PacBio
Sampled Named a Certified Service Provider for PacBio Piscataway, NJ, July 11, 2023 – Sampled1 today announced that it has been named a Certified Service Provider for PacBio, a leading developer of high-quality, highly accurate sequencing solutions, equipping Sampled to deliver the highest quality advanced sequencing technology services on PacBio’s technology. To achieve this certification, […]
Sampled’s Genomics Laboratory in Glasgow Launches Inaugural Project with Guardant Health
Glasgow lab will manage blood samples for the Guardant Health SHIELD lung cancer screening study in the EU. February 1, 2023 – Piscataway, NJ – Sampled1 today announced that the new genomics Sampled Lab in Glasgow, UK, has initiated a project with Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, to manage blood […]
Sampled Leader Highlights Role of Biobanking in Addressing Historic Inequities in Healthcare
Diversity in Bio-sample Collection is Critical to the Development of Personalized Medicines November 15, 2022 – Piscataway, NJ – The Chief Scientific Officer at Sampled1 issued a call to action for greater diversity in clinical trial recruitment and the collection of biosamples in a letter in the current issue of Biopreservation and Biobanking. The letter […]
